Your browser doesn't support javascript.
loading
Safety and efficacy of induction immunochemotherapy with rituximab, methotrexate, ifosfamide, and vincristine (R-MIV) in patients with primary CNS lymphoma including recent COVID-19 pandemic experience.
Ostrowska, Beata; Domanska-Czyz, Katarzyna; Romejko-Jarosinska, Joanna; Osowiecki, Michal; Targonski, Lukasz; Poplawska, Lidia; Konecki, Robert; Kotarska, Martyna; Szymanski, Marcin; Borawska, Anna; Swierkowska, Monika; Dabrowska-Iwanicka, Anna; Druzd-Sitek, Agnieszka; Paszkiewicz-Kozik, Ewa; Mroz-Zycinska, Ewa; Tajer, Joanna; Wojciechowska-Lampka, Elzbieta; Osiadacz, Wlodzimierz; Rymkiewicz, Grzegorz; Lapinska, Grazyna; Wojewodzka-Mirocha, Marta; Michalski, Wojciech; Walewski, Jan.
Afiliação
  • Ostrowska B; Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Domanska-Czyz K; Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Romejko-Jarosinska J; Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Osowiecki M; Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Targonski L; Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Poplawska L; Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Konecki R; Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Kotarska M; Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Szymanski M; Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Borawska A; Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Swierkowska M; Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Dabrowska-Iwanicka A; Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Druzd-Sitek A; Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Paszkiewicz-Kozik E; Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Mroz-Zycinska E; Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Tajer J; Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Wojciechowska-Lampka E; Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Osiadacz W; Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Rymkiewicz G; Flow Cytometry Laboratory, Department of Cancer Pathomorphology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Lapinska G; Department of Oncological Endocrinology and Nuclear Medicine, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Wojewodzka-Mirocha M; Department of Oncological Endocrinology and Nuclear Medicine, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Michalski W; Biostatistics Unit, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Walewski J; Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Br J Haematol ; 201(4): 663-672, 2023 05.
Article em En | MEDLINE | ID: mdl-36762710

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article